Hall, Amy B <br/><br/>
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970.  [electronic resource] 

 -  Oncotarget  Jul 2014 
 - 5674-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.2158  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Ataxia Telangiectasia Mutated Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cisplatin--administration & dosage<br/>DNA--drug effects<br/>DNA Damage<br/>Drug Synergism<br/>Female<br/>Humans<br/>Isoxazoles--pharmacology<br/>Mice<br/>Mice, SCID<br/>Phosphorylation<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrazines--pharmacology<br/>Random Allocation<br/>Signal Transduction<br/>Xenograft Model Antitumor Assays